Media Releases

2022

28/06/2022

QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International – Precision Oncology News

21/06/2022

Proteomics International (ASX:PIQ) secures licence for oesophageal cancer biomarkers – The Market Herald

21/06/2022

Proteomics International secures exclusive licence to oesophageal cancer biomarkers

16/06/2022

Pilot test kit takes Proteomics step closer to sales – The West Australian

16/06/2022

Proteomics International Laboratories (ASX:PIQ) completes PromarkerD manufacturing tech transfer – The Market Herald

16/06/2022

PromarkerD manufacturing tech-transfer completed – Successful production of components for over 50,000 tests

06/06/2022

Study boosts diagnostic potential for Proteomics – The West Australian

06/06/2022

Study shows PromarkerD ability to also predict late-stage kidney decline in type-2 diabetes patients

02/06/2022

PromarkerD registration submitted to the TGA

12/05/2022

Proteomics International awarded funding to support diabetic kidney disease test development – The Market Herald

12/05/2022

Proteomics International awarded $400,000 to support manufacturing capability in Australia

12/04/2022

New Clinical Advisory Board to support PromarkerD global rollout – Yahoo! Finance

12/04/2022

New Clinical Advisory Board for PromarkerD global rollout

24/03/2022

Indian IP win gives Proteomics massive global cover – The West Australian

24/03/2022

PromarkerD patent granted in India

Newsroom

News Archive

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Subscribe

  • This field is for validation purposes and should be left unchanged.
Menu